Anna Ferguson

1.1k total citations
41 papers, 843 citations indexed

About

Anna Ferguson is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Anna Ferguson has authored 41 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 23 papers in Hematology and 11 papers in Molecular Biology. Recurrent topics in Anna Ferguson's work include Multiple Myeloma Research and Treatments (14 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immunotherapy and Immune Responses (9 papers). Anna Ferguson is often cited by papers focused on Multiple Myeloma Research and Treatments (14 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immunotherapy and Immune Responses (9 papers). Anna Ferguson collaborates with scholars based in United States, Australia and United Kingdom. Anna Ferguson's co-authors include Ivan Borrello, Vinay Chaudhry, Carol Ann Huff, Michael Polydefkis, David R. Cornblath, Kimberly Noonan, Lakshmi Rudraraju, Elizabeth M. Jaffee, Marcela F. Pasetti and B. Douglas Smith and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Anna Ferguson

38 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Ferguson United States	13	547	359	358	234	60	41	843
Yasutaka Hoshi Japan	12	233 0.4×	389 1.1×	140 0.4×	291 1.2×	111 1.9×	39	737
Jing‐Zhou Hou United States	14	332 0.6×	367 1.0×	503 1.4×	232 1.0×	115 1.9×	59	967
Sharon Tindle United States	9	312 0.6×	639 1.8×	144 0.4×	153 0.7×	102 1.7×	19	742
Morgan L. McLemore United States	12	213 0.4×	224 0.6×	213 0.6×	110 0.5×	122 2.0×	38	579
Asra Ahmed United States	8	224 0.4×	503 1.4×	118 0.3×	407 1.7×	45 0.8×	16	707
Simona Lapusan France	15	271 0.5×	350 1.0×	109 0.3×	146 0.6×	73 1.2×	33	676
A. Stern Switzerland	8	500 0.9×	627 1.7×	193 0.5×	127 0.5×	98 1.6×	17	1.0k
Emily Curran United States	16	201 0.4×	220 0.6×	263 0.7×	278 1.2×	119 2.0×	42	765
Hai Cheng China	18	485 0.9×	361 1.0×	268 0.7×	345 1.5×	152 2.5×	88	1.2k
Jean‐Yves Cahn France	11	217 0.4×	698 1.9×	221 0.6×	169 0.7×	114 1.9×	14	902

Countries citing papers authored by Anna Ferguson

Since Specialization

Citations

This map shows the geographic impact of Anna Ferguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Ferguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Ferguson more than expected).

Fields of papers citing papers by Anna Ferguson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Ferguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Ferguson. The network helps show where Anna Ferguson may publish in the future.

Co-authorship network of co-authors of Anna Ferguson

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Ferguson. A scholar is included among the top collaborators of Anna Ferguson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Ferguson. Anna Ferguson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baretti, Marina, Brian H. Ladle, Julie M. Nauroth, et al.. (2023). 641 A pilot study of a DNAJB1-PRKACA fusion kinase peptide vaccine combined with nivolumab and ipilimumab for patients with fibrolamellar hepatocellular carcinoma. SHILAP Revista de lepidopterología. A733–A734. 1 indexed citations

Huff, Carol Ann, Anna Ferguson, Lakshmi Rudraraju, et al.. (2021). An Allogeneic Multiple Myeloma GM-CSF–Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete Remission. Clinical Cancer Research. 27(24). 6696–6708. 12 indexed citations

Webster, Jonathan, Tara M. Robinson, Amanda L. Blackford, et al.. (2021). A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CML. Leukemia Research. 111. 106737–106737. 4 indexed citations

Wu, Annie A., Katherine M. Bever, Won Jin Ho, et al.. (2020). A Phase II Study of Allogeneic GM-CSF–Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer. Clinical Cancer Research. 26(19). 5129–5139. 91 indexed citations

Huff, Carol Ann, Anna Ferguson, Lakshmi Rudraraju, et al.. (2020). Treating MRD Positivity in Multiple Myeloma: An Allogeneic GM-CSF-Based Vaccine in Combination with Lenalidomide Induces Long-Term Remissions in Patients with Low Disease Burden. Blood. 136(Supplement 1). 8–8. 1 indexed citations

Yarchoan, Mark, Chiung‐Yu Huang, Qingfeng Zhu, et al.. (2019). A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer. Cancer Medicine. 9(4). 1485–1494. 68 indexed citations

Popović, Aleksandra, Elizabeth A. Sugar, Anna Ferguson, et al.. (2019). Abstract CT207: Feasibility of neoadjuvant cabozantinib plus nivolumab followed by definitive resection for patients with locally advanced hepatocellular carcinoma: A Phase Ib trial (NCT03299946). Cancer Research. 79(13_Supplement). CT207–CT207. 2 indexed citations

Yarchoan, Mark, Anna Ferguson, Jennifer N. Durham, et al.. (2019). A phase II study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair–proficient (MMR-p) advanced colorectal cancer.. Journal of Clinical Oncology. 37(4_suppl). 563–563. 7 indexed citations

Popović, Aleksandra, Elizabeth A. Sugar, Anna Ferguson, et al.. (2019). Abstract CT207: Feasibility of neoadjuvant cabozantinib plus nivolumab followed by definitive resection for patients with locally advanced hepatocellular carcinoma: A Phase Ib trial (NCT03299946). Clinical Trials. CT207–CT207. 2 indexed citations

10.

Zeidan, Amer M., Hanna A. Knaus, Tara M. Robinson, et al.. (2018). A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure. Clinical Cancer Research. 24(15). 3519–3527. 74 indexed citations

11.

Robinson, Tara M., Gabrielle T. Prince, Christopher J. Thoburn, et al.. (2018). Pilot trial of K562/GM-CSF whole-cell vaccination in MDS patients. Leukemia & lymphoma. 59(12). 2801–2811. 9 indexed citations

12.

Norsworthy, Kelly J., Eunpi Cho, Jyoti Arora, et al.. (2016). Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studies. Leukemia Research. 49. 90–97. 11 indexed citations

13.

Borrello, Ivan, et al.. (2015). Allogeneic myeloma GVAX with lenalidomide in near complete remission to enhance progression free survival.. Journal of Clinical Oncology. 33(15_suppl). 3082–3082. 3 indexed citations

14.

Thomas, Veronica G., et al.. (2013). Implementing the NICE clinical guideline 91 (‘Depression in adults with a chronic physical health problem’) in a haematology department. Clinical Psychology Forum. 1(246). 41–45. 3 indexed citations

15.

Noonan, Kimberly, Lakshmi Rudraraju, Anna Ferguson, et al.. (2012). Lenalidomide-Induced Immunomodulation in Multiple Myeloma: Impact on Vaccines and Antitumor Responses. Clinical Cancer Research. 18(5). 1426–1434. 83 indexed citations

16.

Ghosh, Nilanjan, Xiaobu Ye, Anna Ferguson, Carol Ann Huff, & Ivan Borrello. (2011). Bortezomib and thalidomide, a steroid free regimen in newly diagnosed patients with multiple myeloma. British Journal of Haematology. 152(5). 593–599. 20 indexed citations

17.

Ghosh, Nilanjan, Anna Ferguson, Xiaobu Ye, Carol Ann Huff, & Ivan Borrello. (2009). Bortezomib and Thalidomide, a Steroid Free Regimen in Newly Diagnosed Patients with Multiple Myeloma.. Blood. 114(22). 2867–2867.

18.

Chaudhry, Vinay, David R. Cornblath, Michael Polydefkis, Anna Ferguson, & Ivan Borrello. (2008). Characteristics of bortezomib‐ and thalidomide‐induced peripheral neuropathy. Journal of the Peripheral Nervous System. 13(4). 275–282. 136 indexed citations

19.

Noonan, Kimberly, Anna Ferguson, Carol Ann Huff, et al.. (2008). The Immunomodulatory Role of Lenalidomide on Prevnar® Responses in Patients with Relapsed Multiple Myeloma: A Comprehensive Analysis of the Immune Response. Blood. 112(11). 2772–2772. 9 indexed citations

20.

Ferguson, Anna, et al.. (1963). The Nurse's Role in Psychiatric Out-Patient Clinics1. Journal of Psychosocial Nursing and Mental Health Services. 1(1). 34–68. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact